Real-world impact of the CwPAMS programme


The Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programme Phase 1 Impact Report demonstrates the real-world impacts that CwPAMS delivers across the world.

Funded by the Fleming Fund, the CwPAMS programme leverages the expertise of UK health institutions and technical experts to strengthen the capacity of the national health workforce and institutions in eight partner countries to address AMR challenges, as well as creating opportunities for bidirectional learning.


Delivered by Global Health Partnerships (formally THET) and the Commonwealth Pharmacist Association (CPA), CwPAMS helps to tackle AMR by using the well-tested methodology of Health Partnerships. CwPAMS focuses on improving and maintaining health workforce capacity to prevent morbidity and mortality associated with antimicrobial use.

Overall, as a result of CwPAMS activities, health practitioners have begun to apply the knowledge gained into AMS practices. This has resulted in positive changes demonstrated through clear empirical evidence such as pharmacist upskilling and recognition, resulting in increased inclusion of pharmacists on the wards and on committees.

To read more about the impact from phase 1 of the programme, please read the Phase 1 Impact Report here. More information about current programme (Phase 2) also available here.


CwPAMs Phase 1 Impact Report

View zip CwPAMs Phase 1 Impact Report (4.94 MB)

More Like This

In April 2022, the Commonwealth Pharmacists Association (CPA) held the first stakeholder meeting since the start of the pandemic. Representatives from 10 African countries joined for training, networking, sharing and learning activities in Entebbe, Uganda.

The Commonwealth Pharmacists Association (CPA), in partnership with the Tropical Health Education Trust (THET) and funded by the Fleming Fund, developed the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programme. The CPA also has a longstanding history of running campaigns on World Antimicrobial Awareness Week (WAAW), which takes place annually between the 18th and 24th of November. WAAW aims to improve the understanding of what antimicrobial medicines are and how their misuse and overuse in humans, animals and the environment are accelerating the speed at which microbes are adapting to resist their effect.